402 related articles for article (PubMed ID: 32165208)
1. Serum Biomarkers Identify Patients Who Will Develop Inflammatory Bowel Diseases Up to 5 Years Before Diagnosis.
Torres J; Petralia F; Sato T; Wang P; Telesco SE; Choung RS; Strauss R; Li XJ; Laird RM; Gutierrez RL; Porter CK; Plevy S; Princen F; Murray JA; Riddle MS; Colombel JF
Gastroenterology; 2020 Jul; 159(1):96-104. PubMed ID: 32165208
[TBL] [Abstract][Full Text] [Related]
2. Serologic testing with ANCA, ASCA, and anti-OmpC in children and young adults with Crohn's disease and ulcerative colitis: diagnostic value and correlation with disease phenotype.
Zholudev A; Zurakowski D; Young W; Leichtner A; Bousvaros A
Am J Gastroenterol; 2004 Nov; 99(11):2235-41. PubMed ID: 15555007
[TBL] [Abstract][Full Text] [Related]
3. Anti-Saccharomyces cerevisiae mannan antibodies combined with antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease: prevalence and diagnostic role.
Quinton JF; Sendid B; Reumaux D; Duthilleul P; Cortot A; Grandbastien B; Charrier G; Targan SR; Colombel JF; Poulain D
Gut; 1998 Jun; 42(6):788-91. PubMed ID: 9691915
[TBL] [Abstract][Full Text] [Related]
4. Association of Anti-glycan Antibodies and Inflammatory Bowel Disease Course.
Paul S; Boschetti G; Rinaudo-Gaujous M; Moreau A; Del Tedesco E; Bonneau J; Presles E; Mounsef F; Clavel L; Genin C; Flourié B; Phelip JM; Nancey S; Roblin X
J Crohns Colitis; 2015 Jun; 9(6):445-51. PubMed ID: 25895876
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic role and clinical correlates of anti-Saccharomyces cerevisiae antibodies (ASCA) and anti-neutrophil cytoplasmic antibodies (p-ANCA) in Italian patients with inflammatory bowel diseases.
Saibeni S; Folli C; de Franchis R; Borsi G; Vecchi M
Dig Liver Dis; 2003 Dec; 35(12):862-8. PubMed ID: 14703881
[TBL] [Abstract][Full Text] [Related]
6. Serological markers predict inflammatory bowel disease years before the diagnosis.
van Schaik FD; Oldenburg B; Hart AR; Siersema PD; Lindgren S; Grip O; Teucher B; Kaaks R; Bergmann MM; Boeing H; Carbonnel F; Jantchou P; Boutron-Ruault MC; Tjønneland A; Olsen A; Crowe FL; Peeters PH; van Oijen MG; Bueno-de-Mesquita HB
Gut; 2013 May; 62(5):683-8. PubMed ID: 22842615
[TBL] [Abstract][Full Text] [Related]
7. Serological antibodies and surgery in a population-based inception cohort of Crohn's disease patients - the IBSEN study.
Kristensen VA; Cvancarova M; Høivik ML; Moum B; Vatn MH
Scand J Gastroenterol; 2020 Apr; 55(4):436-441. PubMed ID: 32252542
[No Abstract] [Full Text] [Related]
8. Antibodies to Escherichia coli outer membrane porin C in the absence of anti-Saccharomyces cerevisiae antibodies and anti-neutrophil cytoplasmic antibodies are an unreliable marker of Crohn disease and ulcerative colitis.
Davis MK; Andres JM; Jolley CD; Novak DA; Haafiz AB; González-Peralta RP
J Pediatr Gastroenterol Nutr; 2007 Oct; 45(4):409-13. PubMed ID: 18030205
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic value of antineutrophil cytoplasmic antibodies and anti-Saccharomyces cerevisiae antibody in Iranian patients with inflammatory bowel disease.
Bahari A; Aarabi M; Aarabi M; Hedayati M; Jarollahi A; Firouzi F; Aghazadeh R; Zali MR; Hashemi M
Acta Gastroenterol Belg; 2009; 72(3):301-5. PubMed ID: 19902862
[TBL] [Abstract][Full Text] [Related]
10. pANCA and ASCA in Children with IBD-Unclassified, Crohn's Colitis, and Ulcerative Colitis-A Longitudinal Report from the IBD Porto Group of ESPGHAN.
Birimberg-Schwartz L; Wilson DC; Kolho KL; Karolewska-Bochenek K; Afzal NA; Spray C; Romano C; Lionetti P; Hauer AC; Martinez-Vinson C; Veres G; Escher JC; Turner D;
Inflamm Bowel Dis; 2016 Aug; 22(8):1908-14. PubMed ID: 27135480
[TBL] [Abstract][Full Text] [Related]
11. Antineutrophil cytoplasmic antibodies, anti-Saccharomyces cerevisiae antibodies, and specific IgE to food allergens in children with inflammatory bowel diseases.
Bartůnková J; Kolárová I; Sedivá A; Hölzelová E
Clin Immunol; 2002 Feb; 102(2):162-8. PubMed ID: 11846458
[TBL] [Abstract][Full Text] [Related]
12. Anti-Saccharomyces cerevisiae mannan antibodies and antineutrophil cytoplasmic autoantibodies in Greek patients with inflammatory bowel disease.
Koutroubakis IE; Petinaki E; Mouzas IA; Vlachonikolis IG; Anagnostopoulou E; Castanas E; Maniatis AN; Kouroumalis EA
Am J Gastroenterol; 2001 Feb; 96(2):449-54. PubMed ID: 11232689
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic role of anti-Saccharomyces cerevisiae mannan antibodies combined with antineutrophil cytoplasmic antibodies in patients with inflammatory bowel disease.
Kim BG; Kim YS; Kim JS; Jung HC; Song IS
Dis Colon Rectum; 2002 Aug; 45(8):1062-9. PubMed ID: 12195191
[TBL] [Abstract][Full Text] [Related]
14. Anti-Saccharomyces cerevisiae and antineutrophil cytoplasmic antibodies as predictors of inflammatory bowel disease.
Israeli E; Grotto I; Gilburd B; Balicer RD; Goldin E; Wiik A; Shoenfeld Y
Gut; 2005 Sep; 54(9):1232-6. PubMed ID: 16099791
[TBL] [Abstract][Full Text] [Related]
15. [Diagnostic role of anti-saccharomyces cerevisiae and antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease].
Gao X; Hu PJ; He Y; Liao SY; Peng S; Chen MH
Zhonghua Nei Ke Za Zhi; 2005 Jun; 44(6):428-30. PubMed ID: 16008854
[TBL] [Abstract][Full Text] [Related]
16. Antineutrophil cytoplasmic autoantibodies and anti-Saccharomyces cerevisiae antibodies in inflammatory bowel diseases.
Kiliç ZM; Tunç B; Ayaz S; Filik L; Aktaş S; Parlak E; Ulker A
Turk J Gastroenterol; 2004 Dec; 15(4):238-42. PubMed ID: 16249978
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of serological markers to differentiate between ulcerative colitis and Crohn's disease: pANCA, ASCA and agglutinating antibodies to anaerobic coccoid rods.
Linskens RK; Mallant-Hent RC; Groothuismink ZM; Bakker-Jonges LE; van de Merwe JP; Hooijkaas H; von Blomberg BM; Meuwissen SG
Eur J Gastroenterol Hepatol; 2002 Sep; 14(9):1013-8. PubMed ID: 12352222
[TBL] [Abstract][Full Text] [Related]
18. Characteristics of inflammatory bowel disease serology in patients with indeterminate colitis.
Sura SP; Ahmed A; Cheifetz AS; Moss AC
J Clin Gastroenterol; 2014 Apr; 48(4):351-5. PubMed ID: 24492405
[TBL] [Abstract][Full Text] [Related]
19. pANCA and ASCA in the diagnosis of different subtypes of inflammatory bowel disease.
Mokrowiecka A; Gasiorowska A; Malecka-Panas E
Hepatogastroenterology; 2007; 54(77):1443-8. PubMed ID: 17708273
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic precision of anti-Saccharomyces cerevisiae antibodies and perinuclear antineutrophil cytoplasmic antibodies in inflammatory bowel disease.
Reese GE; Constantinides VA; Simillis C; Darzi AW; Orchard TR; Fazio VW; Tekkis PP
Am J Gastroenterol; 2006 Oct; 101(10):2410-22. PubMed ID: 16952282
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
